Join us as we hear from two Korean companies working to bring NK cell-based therapies to market. Both CAR-modified NK cells to treat malignant and recurrent blood cancers as well as combination therapy of NK cells and local immunogenic chemotherapy to treat hepatocellular carcinoma will be...
ISCT Webinar_Natural Killer (NK) Cell-based Strategies-06-28.mp4
The voting period for the ISCT 2022-2023 Insta-Your-Cells Photo Challenge is now closed Prizes The first three prizes include a complimentary registration to ISCT 2023 Paris in addition to: 1st Place: Image showcased on cover of May 2023 Issue of Cytotherapy + a framed keepsake of...